Evaluation of a Novel Home‐Based Pathway to Support Early Detection and Diagnosis of Alzheimer's Disease
This novel home-based pathway is a promising approach for the collection of digital cognitive assessments and ADRD plasma biomarkers, potentially aiding in early diagnosis and informing disease modifying treatment eligibility. Importantly, this pathway may also reduce barriers to testing and expanding access to dementia care.
Authors
- Alexandra J. Weigand (ORCID: https://orcid.org/0000-0002-7931-1383)
- Michael K. Racke (ORCID: https://orcid.org/0000-0002-1231-4694)
- Kelly J. Atkins (ORCID: https://orcid.org/0000-0003-0361-2494)
- Sabrina J. Erlhoff
- Julia A Larsen
- Charles Windon (ORCID: https://orcid.org/0000-0001-8719-1206)
- Katherine L. Possin (ORCID: https://orcid.org/0000-0002-6623-3793)
- Argentina Lario Lago
- Elena Tsoy
- Peggye Dilworth‐Anderson
- Tiffany R. Brailow
- Claudio Reck‐Rivera
Institutions
- University of North Carolina at Chapel Hill (US)
- University of California, San Francisco (US)
- University Memory and Aging Center (US)
- Global Brain Health Institute (US)
- Quest Diagnostics (United States) (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_103571
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00